Magic mushroom compound may ease despair in advanced cancer patients
Symptom relief
Recruiting now
This pilot study tests whether psilocybin (the active ingredient in magic mushrooms) combined with talk therapy can safely reduce demoralization in people with advanced cancer. Fifteen participants aged 18-70 will receive one 25 mg dose of psilocybin during an 8-hour supervised s…
Phase: PHASE1 • Sponsor: Gustavo Vazquez • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC